Navigation Links
US Oncology Research Affiliated Physicians to Present at 2011 ASCO Annual Meeting
Date:5/26/2011

_li"/>

Patterns of Care and Patient Characteristics in Post-menopausal Women with HER2+ and Hormone Receptor Positive (HR+) Metastatic Breast Cancer (MBC).Dean Gesme, MD, FACP, FACPE, Minnesota Oncology


  • Risk of treatment failure after first-line tyrosine kinase inhibitors (TKI) therapy in patients with metastatic renal cell carcinoma.Joanne Blum, MD, Texas Oncology


  • Capecitabine (Cap) monotherapy in anthracycline (A)-/taxane – (T) pretreated MBC.Presentations from McKesson:Poster:Zhaohui Wang, McKesson Specialty Care SolutionsPoster #32B

    Saturday, June 4, 2:00 PM – 6:00 PM, Hall A


  • Guideline adherence rates and costs of chemotherapy treatment for NSCLC patients treated in U.S. community oncology practices.Publish Only:Brandon Tom, McKesson Corporation


  • Leveraging technology and data to facilitate development of cost-effective pathways.About McKesson Specialty Care Solutions | US OncologyMcKesson Specialty Care Solutions | US Oncology, a division of McKesson Corporation, empowers the community patient care delivery system to advance the science, technology and quality of care. Through innovative clinical, research, business and operational solutions, facilitated by integrated technology systems, we improve the financial health of our customers and help them provide quality care for patients. For more information, visit www.mckesson.com/specialty and www.usoncology.com.

    About US Oncology ResearchMcKesson Specialty Care Solutions | US Oncology conducts clinical research through US Oncology Research, its wholly-owned subsidiary uniting one of the nation's largest community-based cancer research networks. US Oncology Research has experienced investigators and dedicated research nurses who specialize in Phase I th
    '/>"/>


  • SOURCE US Oncology, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
    2. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
    3. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
    4. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
    5. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
    6. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
    7. Statement by US Oncology on FDA Label on Erythropoiesis Stimulating Agents (ESAs)
    8. Pharsight Uses FDA Disease Model to Support Oncology Drug Development
    9. US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium
    10. IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
    11. Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/27/2015)... 2015  Delcath Systems, Inc. (NASDAQ: DCTH ... focused on oncology with an emphasis on the ... the reporting of data from a single -center ... with the Delcath Hepatic Delivery System (Melphalan/HDS) and ... Society of Surgical Oncology (SSO) Annual Meeting 2015.  ...
    (Date:3/27/2015)... , March 27, 2015  WebMD Health ... source of health information, today announced an ... National Action Plan for Combating Antibiotic-Resistant ... emphasized the urgency and importance of addressing ... and global health.    The WebMD ...
    (Date:3/26/2015)... - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), ... therapies for cardiovascular disease and overall health, announced that ... of the Corporation (the "Common Shares"). The Common Shares ... 5 th , 2014 to March 4 th , ... on or before April 1, 2015. Interest on the ...
    Breaking Medicine Technology:Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 3Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2
    (Date:3/27/2015)... When struck with the aftermath of ... where to begin. The latest eBook released by ... offers accident victims a clear and concise process for ... their personal injury claim is seen through to successful ... actions that should be taken immediately following the trucking ...
    (Date:3/27/2015)... 2015 Trail mix is the perfect, healthy ... weekend hikes and during the game! It’s portable, lightweight and ... proud to introduce a new line of specialty trail mixes ... and flavorful selections packed with nutritious, 100% all natural ingredients. ... grains that add protein and fiber to your diet and ...
    (Date:3/27/2015)... (PRWEB) March 27, 2015 Approximately ... for Healthy Kids Coalition Lobby Day to lobby ... Health Improvement Program (SHIP). Everlast Climbing was ... PE Bill SF343/HF498 which would strengthen physical education ... student assessments and other measures to strengthen physical ...
    (Date:3/27/2015)... 27, 2015 Since September 2014, the country ... comeback tour after having been in retirement for a period ... the performer to return to touring, and concert events have ... Omaha will likely sell out for the two shows recently ... to view the inventory of discounted Garth Brooks tickets ...
    (Date:3/27/2015)... Canadian Cannabis Clinics ( http://www.cannabisclinics.ca ... utilization of medical cannabis as a treatment for ... and clinics dedicated to providing access to safe ... for patients searching for medical marijuana treatment in ... their sub domain for Canada. , With ...
    Breaking Medicine News(10 mins):Health News:Dax Jones Updated eBook on Trucking Accidents Offers Helpful Information to Crash Victims 2Health News:Aurora Product, Inc. Introduces New Line of Specialty Trail Mixes 2Health News:Everlast Climbing Advocates to Strengthen Physical Education in Minnesota Schools 2Health News:Garth Brooks Tickets for Omaha: BuyCheapTicketsToEvents.com Draws Customers by Discounting Prices on 2015 Tickets for Garth Brooks’ Tour Stops at CenturyLink Center 2Health News:Canadian Cannabis Clinics (CCC) to Join the Canada.MarijuanaDoctors.com Network 2
    ... for regulating the immune system, an international team of ... that have the potential to treat diseases involving inflammation, ... The team started by creating a three-dimensional map of ... on the surface of human cells and plays a ...
    ... HealthDay Reporter , MONDAY, May 14 (HealthDay News) -- ... may help relieve shortness of breath during activity, Japanese ... that makes it hard to breathe; it is commonly ... "The effects of acupuncture are large," said Dr. George ...
    ... , SUNDAY, May 13 (HealthDay News) -- A new type ... people who have lost their vision due to degenerative eye ... research with rats. The system uses tiny solar panel-like ... a specially designed pair of goggles equipped with a miniature ...
    ... study has found that, contrary to current thinking, taking beta ... person,s risk of developing colorectal cancer. Published early online in ... Society, the study also revealed that even long-term use or ... risk. In recent years, researchers have thought that beta ...
    ... May 10 (HealthDay News) -- An advisory panel to the ... the weight-loss medication lorcaserin, even though concerns remain about cardiovascular ... nod to the drug, lorcaserin would become the first new ... FDA is not bound to follow the advice of its ...
    ... cause of death among children under 5, according to a ... School of Public Health. They examined the distribution of child ... percent were attributable to infectious causes and 40 percent occurred ... of the Lancet , suggest a decline in the ...
    Cached Medicine News:Health News:Novel drug candidates offer new route to controlling inflammation 2Health News:Novel drug candidates offer new route to controlling inflammation 3Health News:Acupuncture May Help Ease Symptoms of COPD 2Health News:Acupuncture May Help Ease Symptoms of COPD 3Health News:In Rat Study, Eye Device Shows Promise for Restoring Sight 2Health News:Blood pressure drugs don't protect against colorectal cancer 2Health News:FDA Panel Gives Blessing to New Weight-Loss Drug 2Health News:Pneumonia and preterm birth complications are the leading causes of childhood death 2
    Inquire...
    Blood grouping tubes are available in two formulations, ACD-A, ACD-B or with a CPDA solution. Blood grouping tubes are for blood grouping determinations and also for cell preservation....
    Blood grouping tubes are available in two formulations, ACD-A, ACD-B or with a CPDA solution. Blood grouping tubes are for blood grouping determinations and also for cell preservation....
    ... BD Vacutainer® SST™ ... and a polymer gel ... are used for serum ... also provide an efficient ...
    Medicine Products: